BACKGROUND
Aiming at connecting excellence in clinical research on a global horizon, ICN strives to harmonize the standards for facilitating collaboration among members, in particular in multinational, multicentre clinical studies.
This workgroup targets to work out the objectives and scope of harmonization, and to formulate a realistic implementation plan with solid deliverables. Possible dimensions may include quality standard and quality control, data and IPR ownership, and general contract terms.
MEMBERS
Convener:
| Dr Britta Lang | Clinical Trials Unit Freiburg, Albert-Ludwigs-University of Freiburg, University Hospital Freiburg, Freiburg |
Contributors:
| Academic Clinical Research Office, Khon Kaen |
| Baim Institute for Clinical Research, Boston |
| Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge |
| University of Istanbul Center of Excellence for Clinical Research, Istanbul |
| Centre for Clinical Trials Essen, Essen |
| Clinical Trial Center, China Medical University Hospital, Taichung |
| Clinical Trial Center, Department of Research, Hualien Tzu Chi General Hospital, Hualien |
| Clinical Trials Center, University of Zurich and University Hospital Zurich, Zurich |
| Clinical Trials Centre, The University of Hong Kong, Hong Kong |
| Infectious Diseases Institute, Kampala |
| Institute for Advancement of Clinical and Translational Science, Kyoto University and Kyoto University Hospital, Kyoto |
| Medical University of Graz, Graz |
| Muenchner Studienzentrum, Technical University Munich, School of Medicine, Munich |
| Oncology Clinical Trials Unit, College of Medicine, University of Ibadan/University College Hospital Ibadan, Ibadan |
| Research Institute for Healthcare and Medical Management of Moscow Healthcare Department, Moscow |
| Shanghai Clinical Research Center, Shanghai |
| University of South Australia, Adelaide |